Anti-Cancer (Oncology)
| Product Name | CAS No. | Specification | Application | Registration |
| Irinotecan Hydrochloride Trihydrate | 136572-09-3 | 99+% | ||
| Ubenimex Hydrochloride | 65391-42-6 | |||
| (S)-(+)-Camptothecin (CPT) | 7689-03-4 | 98+% | ADC Cytotoxin inhibitor | Topoisomerase inhibitor | Apoptosis related activator | MicroRNA inhibitor | |
| Ibrutinib (PCI-32765) | 936563-96-1 | 98+% | ||
| Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | EGFR | ADC Antibody |Antineoplastic Agent |the treatment of HER2 receptor positive breast cancer | |
| Cetuximab | 205923-56-4 | 95+% | Antineoplastic Agent |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Anti-Cancer (Oncology)
- Vitamin D Series Compounds
- Antibody-Drug Conjugates
- Prostaglandins
- Immunosuppressants
- Cardiovascular
- Antiviral Agents
- Anti-Diabetic
- Peptides
- Veterinary
- Antibacterial
- Miscellaneous
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn